Drug Shortage Report for AURO-ALENDRONATE

Last updated on 2020-03-31 History
Report ID 96271
Drug Identification Number 02388553
Brand name AURO-ALENDRONATE
Common or Proper name Alendronic Acid
Company Name AURO PHARMA INC
Market Status MARKETED
Active Ingredient(s) ALENDRONIC ACID
Strength(s) 70MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 1x4
ATC code M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2019-10-09
Estimated end date
Actual end date 2020-03-30
Shortage status Resolved
Updated date 2020-03-31
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3700 STEELES AVENUE WEST, SUITE 402
WOODBRIDGE, ONTARIO
CANADA L4L 8K8
Company contact information Anahita Rostami

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2020-03-31 French Compare
v9 2020-03-31 English Compare
v8 2020-03-13 French Compare
v7 2020-03-13 English Compare
v6 2019-11-11 French Compare
v5 2019-11-11 English Compare
v4 2019-10-24 French Compare
v3 2019-10-24 English Compare
v2 2019-10-11 French Compare
v1 2019-10-11 English Compare

Showing 1 to 10 of 10